https://www.selleckchem.com/pr....oducts/sacituzumab-g
Background Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that has spread worldwide. Methods This was a retrospective case series involving 218 patients admitted to three tertiary hospitals in the Loudi, Shaoyang, and Xiangtan areas of China from January 21 to June 27, 2020, who were confirmed by RT-PCR to have SARS-CoV-2. The patients' clinical characteristics, laboratory results, treatments, and prognoses based on clinical classification were recorded. Poor outcome was defined as admission to an IC
Aimer
Commentaire
Partagez
